Massachusetts-based NinePoint Medical has raised $30.7 million to go toward its medical imaging technology, according to a SEC filing.
The funding is backed by Third Rock Ventures, Prospect Venture Partners and Corning. NinePoint has previously raised around $68 million. In addition to that, Horizon Venture Technology provided a $15 loan in February, according to Xconomy.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Technology licensed from Massachusetts General Hospital led to NinePoint’s development in 2010. That technology has led to NinePoint’s NvisionVLE system. It allows visibility to large areas of tissue in order to more precisely detect areas that would need to be biopsied, more specifically to examine the esophagus in an endoscopy procedure.
FDA approval was granted for the NvisionVLE system in December 2011 and it began being sold to academic and community hospitals in May 2013.
Photo: Flickr user Pictures of Money
